| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/08/2002 | US20020106404 Compounds that inhibit caspase activity for treating glaucoma |
| 08/08/2002 | US20020106395 Sustained release drug delivery devices with prefabricated permeable plugs |
| 08/08/2002 | US20020106371 For therapy of sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura |
| 08/08/2002 | US20020106360 Administering a modulator of nitric oxide levels to oocyte for modulating oocyte activation |
| 08/08/2002 | US20020106359 Method and composition for treating prostate cancer |
| 08/08/2002 | US20020106357 Crohn's disease treatment methods |
| 08/08/2002 | US20020106354 Cellular and animal models for diseases associated with altered mitochondrial function |
| 08/08/2002 | US20020106348 Contacting cell with agent that increases intracellular superoxide anion and contacting cell with 2-methoxyestradiol for killing a cell |
| 08/08/2002 | US20020106346 Administering to mammal polystyrene sulfonate as broad spectrum immune modulatory compound to modulate humeral and cellular arms of innate and adaptive immunity by modulation of compound selected from Factor H, Factor D, CD4 cells |
| 08/08/2002 | US20020106345 Therapeutic compositions and methods |
| 08/08/2002 | US20020106342 Methods for treating atopic disorders |
| 08/08/2002 | US20020106339 Compositions and methods using direct MMP inhibitors for inhibiting photoaging of skin |
| 08/08/2002 | US20020106338 Galenical formulation |
| 08/08/2002 | US20020106332 Process for preparing powder formulations |
| 08/08/2002 | US20020106330 Sdministering aerosolized drug in an air mixture containing up to about 10% carbon dioxide gas for increasing the deposition of aerosolized drug in the respiratory tract of an individual or animal |
| 08/08/2002 | US20020106329 Transdermal dosage form |
| 08/08/2002 | US20020106324 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family |
| 08/08/2002 | US20020106304 Enhancing the anti-microbial activity of a borate-containing compound which comprises adding to the composition an effective amount of a low molecular weight amino alcohol, wherein the amino alcohol has a molecular weight of 60-200 |
| 08/08/2002 | DE10104880A1 Multipartikuläre Arzneiform, enthaltend mindestens zwei unterschiedlich überzogene Pelletformen A multiparticulate pharmaceutical form comprising at least two differently coated pellet forms |
| 08/08/2002 | DE10104802A1 Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (1) Pharmaceutical formulations containing Thienopirimidine and endothelin receptor antagonist (1) |
| 08/08/2002 | DE10104801A1 Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (2) Pharmaceutical formulations containing Thienopirimidine and endothelin receptor antagonist (2) |
| 08/08/2002 | DE10104800A1 Pharmazeutische Formulierungen enthaltend Pyrazolo[4,3-d]pyrimidine und Endothelin-Rezeptor-Antagonisten Pharmaceutical formulations containing pyrazolo [4,3-d] pyrimidines and endothelin receptor antagonists |
| 08/08/2002 | DE10104370A1 Arzneimittelkompositionen mit geringeren Nebenwirkungen Pharmaceutical compositions with fewer side effects |
| 08/08/2002 | DE10104369A1 Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz Using 2-amino- (4-hydroxy-2-methanesulfonamidophenyl) ethanol for treating urinary incontinence |
| 08/08/2002 | DE10104367A1 Betamimetika enthaltende Arzneimittelkompositionen mit geringeren Nebenwirkungen Betamimetics containing pharmaceutical compositions with fewer side effects |
| 08/08/2002 | DE10104362A1 Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit Crystal modification of a cyclic depsipeptide with better efficacy |
| 08/08/2002 | CA2672805A1 Pyrimidine derivatives |
| 08/08/2002 | CA2444661A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 08/08/2002 | CA2438594A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | CA2437555A1 Stabilised polymeric aerosols for pulmonary gene delivery |
| 08/08/2002 | CA2437044A1 Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 08/08/2002 | CA2436958A1 Pyrimidine acyclonucleoside derivatives, preparation method and use thereof |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk) |
| 08/08/2002 | CA2436744A1 Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells |
| 08/08/2002 | CA2436576A1 Treatment of diabetes mellitus using vardenafil |
| 08/08/2002 | CA2436556A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
| 08/08/2002 | CA2436551A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436544A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436539A1 Ethanolates of sodium-hydrogen exchanger type-1 inhibitor |
| 08/08/2002 | CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436510A1 Pharmaceutical compositions with few side effects |
| 08/08/2002 | CA2436487A1 Methods of inhibiting kinases |
| 08/08/2002 | CA2436429A1 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 08/08/2002 | CA2436425A1 Hypoglycemic agent |
| 08/08/2002 | CA2436418A1 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 08/08/2002 | CA2436397A1 Method of treating certain eye diseases |
| 08/08/2002 | CA2436373A1 Pharmaceutical composition |
| 08/08/2002 | CA2436266A1 Pyk2 phosphorylation by her3 induces tumor invasion |
| 08/08/2002 | CA2436265A1 3-(3-amidinophenyl)-5-[({[1-(1-iminoethyl)-4-piperidyl]methyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same |
| 08/08/2002 | CA2436245A1 Medicament for protection in radiotherapy |
| 08/08/2002 | CA2436209A1 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | CA2436133A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | CA2436130A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | CA2436000A1 An antistress agent |
| 08/08/2002 | CA2435958A1 Pyrimidine compounds and methods for making and using the same |
| 08/08/2002 | CA2435545A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 08/08/2002 | CA2434970A1 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
| 08/08/2002 | CA2434872A1 Medicament compositions with negligible side-effects containing betamimetics |
| 08/08/2002 | CA2434839A1 Muscarinic receptors agonists |
| 08/08/2002 | CA2434565A1 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence |
| 08/08/2002 | CA2434495A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2434491A1 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | CA2434485A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2434242A1 Procedure and composition of treatment and/or care of the eye |
| 08/08/2002 | CA2433553A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle |
| 08/08/2002 | CA2433351A1 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 08/08/2002 | CA2432997A1 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | CA2432981A1 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states |
| 08/08/2002 | CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | CA2431589A1 C-glucosyl ether lipids |
| 08/08/2002 | CA2431559A1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | CA2430878A1 Anticholesterolemic edible oil |
| 08/08/2002 | CA2429969A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | CA2429493A1 Pharmaceutical composition containing aminoacetonitrile compounds and the use thereof for the preparation of a pharmaceutical composition for the treatment of endoparasitic pests in animals |
| 08/08/2002 | CA2427610A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | CA2426587A1 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 08/07/2002 | EP1229332A2 In vitro assay for testing gabapentinoid activity |
| 08/07/2002 | EP1229122A2 Chimeric isoprenoid synthases and uses thereof |
| 08/07/2002 | EP1229040A2 Nucleoside monophosphate derivative, a processor for their production and their use as immunosuppressive drugs |
| 08/07/2002 | EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 08/07/2002 | EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes |
| 08/07/2002 | EP1229026A1 Alkoxyiminoalkanoic acid derivatives |
| 08/07/2002 | EP1228784A2 Preparation for veterinary use |
| 08/07/2002 | EP1228766A1 PYK2 phosphorylation by HER3 induces tumor invasion |
| 08/07/2002 | EP1228761A2 Liquid pharmaceutical composition for treating bone diseases |
| 08/07/2002 | EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 08/07/2002 | EP1228759A2 Pharmaceutical compositions containing a taxane having a furyl or thienyl substituted side-chain |
| 08/07/2002 | EP1228758A1 Preventive or therapeutic agents for inflammatory diseases of intestine |
| 08/07/2002 | EP1228757A1 Stable pharmaceutical solutions of nimesulide |
| 08/07/2002 | EP1228756A1 Agents for relieving carbonyl stress |
| 08/07/2002 | EP1228755A1 Use of biodegradable microspheres for the delivery of an anticancer agent for the treatment of gliblastoma |
| 08/07/2002 | EP1228707A1 Use of alpha-lactalbumin as prebiotic agent |
| 08/07/2002 | EP1228706A1 Composition for enhancing the forming of connective tissue and for conditioning the body for high physical performance |
| 08/07/2002 | EP1228705A2 Process to produce dry powder of a carotenoid or several carotenoids |
| 08/07/2002 | EP1228698A1 Sorbic acid as growth-stabilising feed additive in animal raising |
| 08/07/2002 | EP1228373A2 Diagnosis and therapy of cancer using sgp28-related molecules |
| 08/07/2002 | EP1228367A2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 08/07/2002 | EP1228235A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |